Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages -

出版商

American Medical Association (AMA)

发表日期

2019-10-07

DOI

10.1001/jamaneurol.2019.3365

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started